Page 76 - Read Online
P. 76

Page 6 of 8                  Bilancini et al. Vessel Plus 2021;5:39  https://dx.doi.org/10.20517/2574-1209.2021.14

               tone, protecting microcirculation, and reducing inflammation. In the microcirculation, Ruscus showed a
               protective effect against histamine-and ischemia/reperfusion-induced leakage in the hamster cheek pouch
               model, and these effects appeared to involve α1-adrenoreceptors and muscarinic receptors [46-48] .


               CONCLUSIONS
               Stasis microangiopathy is a pathology with a very complex pathogenesis characterized by the interaction of
               multiple factors. There are still many areas of uncertainty that need further studies to be fully understood.
               Treatment of stasis microangiopathy is based on compression therapy and drugs. Compression therapy
               removes the “upstream” pathological trigger by reducing venous hypertension, which is the “primum
               movens” of the disease. Drugs, on the other hand, act “downstream” on various hemodynamic,
               hemorheological, and biochemical factors, which interact and cause the tissue damage that characterizes
               stasis microangiopathy.


               DECLARATIONS
               Authors’ contributions
               Literature review, manuscript preparation, review of the manuscript: Bilancini S
               Literature review, review of the manuscript: Lucchi M
               Literature review, review and editing of the manuscript: Ciacciarelli M


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2021.

               REFERENCES
              1.       Merlen JF, Santeel AM, Robert JL. Post-phlebitic disease, stasis microangiopathy. Phlebologie 1984;37:409-15. (in French)
               2.       Mansilha A, Sousa J. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int
                   J Mol Sci  2018;19:1669.  DOI  PubMed  PMC
               3.       Curri SB, Annoni F, Montorsi W. Microvalves in microvenules. Phlebologie 1987;40:795-801. :(in French).  PubMed
               4.       Caggiati A, Phillips M, Lametschwandtner A, Allegra C. Valves in small veins and venules. Eur J Vasc Endovasc Surg  2006;32:447-
                   52.  DOI  PubMed
               5.       Vincent JR, Jones GT, Hill GB, van Rij AM. Failure of microvenous valves in small superficial veins is a key to the skin changes of
                   venous insufficiency. J Vasc Surg 2011;54:62S-9S. :e1-3.  DOI  PubMed
               6.       Mortimer BS, Pearson IC. Lymphatic function in severe chronic venous insufficiency. Phlebolymphology  2004;44:253-257.
               7.       Secomb TW, Hsu R, Pries AR. Effect of the endothelial surface layer on transmission of fluid shear stress to endothelial cells.
                   Biorheology  2001;38:143-50.  PubMed
               8.       Levick JR. Capillary filtration-absorption balance reconsidered in light of dynamic extravascular factors. Exp Physiol  1991;76:825-57.
                   DOI  PubMed
               9.       Bräutigam P, Vanscheidt W, Földi E, Krause T, Moser E. [Involvement of the lymphatic system in primary non-lymphogenic edema of
   71   72   73   74   75   76   77   78   79   80   81